Camber Capital Management

Camber Capital Management as of June 30, 2020

Portfolio Holdings for Camber Capital Management

Camber Capital Management holds 30 positions in its portfolio as reported in the June 2020 quarterly 13F filing

Company (Ticker)
Portfolio Weight
Valued At
Change in Shares
Share Count
Share Price
Change Healthcare 10.2 $178M 16M 11.20
Mylan N V Shs Euro 10.1 $177M 11M 16.08
Alexion Pharmaceuticals 9.0 $157M 1.4M 112.24
Alkermes SHS (ALKS) 8.0 $141M 7.3M 19.41
Perrigo SHS (PRGO) 7.1 $124M 2.3M 55.27
Glaxosmithkline Sponsored Adr 7.0 $122M 3.0M 40.79
Universal Hlth Svcs CL B (UHS) 5.3 $93M 1.0M 92.89
Bluebird Bio (BLUE) 4.5 $78M 1.3M 61.04
Nektar Therapeutics (NKTR) 4.0 $70M 3.0M 23.16
Ironwood Pharmaceuticals Com Cl A (IRWD) 3.8 $67M 6.5M 10.32
Sarepta Therapeutics (SRPT) 3.7 $64M 400k 160.34
Ascendis Pharma A S Sponsored Adr (ASND) 3.0 $52M 350k 147.90
Myriad Genetics (MYGN) 2.6 $45M 4.0M 11.34
Brookdale Senior Living (BKD) 2.5 $44M 15M 2.95
Coherus Biosciences (CHRS) 2.2 $39M 2.2M 17.86
Collegium Pharmaceutical Inc Common Stock Usd (COLL) 2.0 $35M 2.0M 17.50
AMAG Pharmaceuticals 1.9 $34M 4.4M 7.65
Glaukos (GKOS) 1.6 $28M 730k 38.42
Puma Biotechnology (PBYI) 1.4 $25M 2.4M 10.43
Teva Pharmaceutical Inds Sponsored Ads (TEVA) 1.4 $25M 2.0M 12.33
Avrobio Ord (AVRO) 1.3 $24M 1.4M 17.45
Sage Therapeutics (SAGE) 1.2 $22M 525k 41.58
Atara Biotherapeutics 1.2 $20M 1.4M 14.57
Immunovant (IMVT) 1.1 $20M 800k 24.35
Translate Bio 1.0 $18M 1.0M 17.92
Momenta Pharmaceuticals 0.9 $15M 450k 33.27
Glycomimetics (GLYC) 0.6 $11M 3.0M 3.76
Pacific Biosciences Calif In 0.6 $11M 3.1M 3.45
Radius Health Com New 0.3 $5.1M 375k 13.63
Sutro Biopharma (STRO) 0.3 $4.7M 600k 7.76